Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Fresenius Medical Care AG (FMCQF) Shares Repurchased (2013 - 2020)

Fresenius Medical Care AG (FMCQF) posted Shares Repurchased of -$165.1 million for Q2 2020, up 30.81% on a QoQ basis from -$238.6 million in Q1 2020, and up 29.89% year-over-year from -$127.1 million in Q3 2019.

Fresenius Medical Care AG (FMCQF) has 4 years of Shares Repurchased data on file, last reported at -$165.1 million in Q2 2020.

  • In Q2 2020, Shares Repurchased rose 29.89% year-over-year to -$165.1 million; the TTM figure through Sep 2020 stood at -$587.8 million (up 3.3% YoY), while the FY2017 annual figure was -$807.4 million, down 232.98% from the prior year.
  • Shares Repurchased advanced to -$165.1 million in Q2 2020, from -$238.6 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $44.4 million in Q2 2018 and bottomed at -$238.6 million in Q1 2020.
  • A 3-year average of -$138.2 million and a median of -$165.1 million in 2020 frame the typical range for Shares Repurchased.
  • Annual changes were most pronounced in 2019 — Shares Repurchased sank 630.02% — and 2020, when it gained 29.89%.
  • Year by year, Shares Repurchased stood at -$86.6 million in 2018, then plunged by 112.66% to -$184.1 million in 2019, then rose by 10.35% to -$165.1 million in 2020.
  • The last three Shares Repurchased figures came in at -$165.1 million (Q2 2020), -$238.6 million (Q1 2020), and -$184.1 million (Q3 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 1.57 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 318.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 196.37 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 71.60 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 163.85 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 190.04 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Fresenius Medical Care AG - - 22,843.10 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 -165.07 Mn
Jun 30, 2020 -165.07 Mn
Mar 31, 2020 -238.59 Mn
Mar 31, 2020 -238.59 Mn
Sep 30, 2019 -184.13 Mn
Sep 30, 2019 -184.13 Mn
Jun 30, 2019 -235.44 Mn
Jun 30, 2019 -235.44 Mn
Mar 31, 2019 -101.67 Mn
Mar 31, 2019 -101.67 Mn
Sep 30, 2018 -86.59 Mn
Sep 30, 2018 -86.59 Mn
Jun 30, 2018 44.42 Mn
Jun 30, 2018 44.42 Mn
Sep 30, 2013 -274.36 Mn
Sep 30, 2013 -274.36 Mn